Daclizumab Subcutaneous and Pedia-Lax Chewable
Determining the interaction of Daclizumab Subcutaneous and Pedia-Lax Chewable and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: magnesium hydroxide
Brand name: Ex-Lax Milk of Magnesia, Milk of Magnesia, Pedia-Lax Chewable, Phillips Milk of Magnesia, Dulcolax Milk of Magnesia, Concentrated Phillips Milk of Magnesia
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Pedia-Lax Liquid rectal
- Daclizumab Subcutaneous-Pediacare
- Daclizumab Subcutaneous-PediaCare Children’s Multi-Symptom
- Daclizumab Subcutaneous-PediaCare Cold/Allergy
- Daclizumab Subcutaneous-Pediacare Decongestant Infants
- Daclizumab Subcutaneous-Pediacare Long-Acting Cough
- Pedia-Lax Chewable-Dacogen
- Pedia-Lax Chewable-Dacomitinib
- Pedia-Lax Chewable-Dactinomycin
- Pedia-Lax Chewable-Dactinomycin Injection
- Pedia-Lax Chewable-Dactinomycin Intravenous
- Pedia-Lax Chewable-Daklinza